Literature DB >> 9563512

Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation.

T Thorlin1, R S Roginski, K Choudhury, M Nilsson, L Rönnbäck, E Hansson, P S Eriksson.   

Abstract

The excitatory effect of presynaptically released glutamate is tightly regulated and terminated by high affinity sodium-dependent glutamate transporters. The regulation of the glial glutamate transporter GLT-1 is potentially important in synaptic modulation. Using astroglial cultures prepared from the rat cerebral cortex, we found that the delta-opioid receptor agonist [D-pen2,D-pen5]-enkephalin decreases and glutamate increases the expression of the GLT-1 transporter mRNA. Corresponding changes in the uptake kinetics were found after incubation for 48 h with the respective agonists when glial glutamate uptake was measured in primary astroglial cultures. The data suggest that long-term receptor activation induces alterations in glial glutamate uptake properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563512     DOI: 10.1016/s0014-5793(98)00288-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes.

Authors:  Jianfeng Liang; Dongman Chao; Harleen K Sandhu; Yanbing Yu; Li Zhang; Gianfranco Balboni; Dong H Kim; Ying Xia
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

2.  Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function.

Authors:  Jamie Raudensky; Bryan K Yamamoto
Journal:  Brain Res       Date:  2007-01-02       Impact factor: 3.252

Review 3.  Evidence for an astrocytic glutamate transporter deficit in hepatic encephalopathy.

Authors:  H Chan; R F Butterworth
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

Review 4.  Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders.

Authors:  Douglas J Roberts-Wolfe; Peter W Kalivas
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

5.  Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion.

Authors:  X Wu; T Kihara; H Hongo; A Akaike; T Niidome; H Sugimoto
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

6.  Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

Authors:  Jianren Mao; Backil Sung; Ru-Rong Ji; Grewo Lim
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

7.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

8.  Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine.

Authors:  Lawrence P Reagan; Daniel R Rosell; Gwendolyn E Wood; Michael Spedding; Carmen Muñoz; Jeffrey Rothstein; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

9.  cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in rats.

Authors:  Xu Liu; Haibiao Guo; Mohammad Daud Som Sayed; Yang Lu; Ting Yang; Dongsheng Zhou; Zhongming Chen; Haitao Wang; Chuang Wang; Jiangping Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-21       Impact factor: 2.570

10.  Neuropathological alterations in drug abusers : The involvement of neurons, glial, and vascular systems.

Authors:  Andreas Büttner; Serge Weis
Journal:  Forensic Sci Med Pathol       Date:  2006-06       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.